Sign in Check my fit
EN
EnglishБългарскиČeštinaDanskDeutschΕλληνικάEspañolEestiSuomiFrançaisGaeilgeHrvatskiMagyarItalianoLietuviųLatviešuMaltiNederlandsNorskPolskiPortuguêsRomânăSlovenčinaSlovenščinaSvenska
Home / US Department of Health and Human Services / RFA-NS-26-001

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Open now · Cooperative Agreement · RFA-NS-26-001

Check my fit, free Open the official call ↗
Next cut-off
10 Nov '26
in 65 days
Per grant
$10M
the call's own average
Grants expected
4
projects that will be funded
Funding rate
,
not published, read the conditions

In context of US Department of Health and Human Services

This grant$10M
The track runs to the largest grant in US Department of Health and Human Services ($42M). The median across the 961 calls we publish is $749K, this one is above it.

What this call funds

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.

What applying costs you

ItemEstimateNote
Drafting effort3–4 weekssingle submission
Time to first payment6–9 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in HHS

CallNext cut-offPer grant
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)PAR-25-038 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)PAR-25-193 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)PAR-25-066 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)PAR-25-064 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)PAR-25-039 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit